Head and Neck Neoplasms — A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer
Citation(s)
A Phase I/IIB Study of Combination Weekly Carboplatin, Cetuximab and Dose Escalation of RAD001 in Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)